XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.2
Long-Term Investments (Details) - Schedule of Ownership Percentages of Investee
 6 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Braingenesis Biotechnology Co., Ltd. [Member]    
Long-Term Investments (Details) - Schedule of Ownership Percentages of Investee [Line Items]    
Ownership percentage 0.22% 0.22%
Accounting treatments Cost Method  
Genepharm Biotech Corporation [Member]    
Long-Term Investments (Details) - Schedule of Ownership Percentages of Investee [Line Items]    
Ownership percentage 0.92% 0.92%
Accounting treatments Cost Method  
BioHopeKing Corporation [Member]    
Long-Term Investments (Details) - Schedule of Ownership Percentages of Investee [Line Items]    
Ownership percentage 8.03% 8.03%
Accounting treatments Cost Method  
BioFirst Corporation [Member]    
Long-Term Investments (Details) - Schedule of Ownership Percentages of Investee [Line Items]    
Ownership percentage 21.77% 21.77%
Accounting treatments Equity Method  
Rgene Corporation [Member]    
Long-Term Investments (Details) - Schedule of Ownership Percentages of Investee [Line Items]    
Ownership percentage 28.85% 28.85%
Accounting treatments Equity Method